DISCOUNT ZERTIFIKAT - STRYKER CORP. Share Price

Certificat

DE000ME7GM37

Market Closed - Bid/Ask 17:58:03 13/05/2024 BST After market 20:42:32
248.9 EUR -0.26% Intraday chart for DISCOUNT ZERTIFIKAT - STRYKER CORP. 249.1 +0.05%
Current month-0.53%
1 month+0.16%
Date Price Change Volume
13/05/24 248.9 -0.26% 0
10/05/24 249.6 +0.14% 0
09/05/24 249.2 -0.16% 0
08/05/24 249.6 +0.18% 0
07/05/24 249.2 +0.29% 0

Delayed Quote Börse Stuttgart

Last update May 13, 2024 at 05:58 pm

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME7GM3
ISINDE000ME7GM37
Date issued 24/01/2024
Maturity 20/09/2024 (130 Days)
Parity 1 : 1
Emission price 242.5
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 250.9
Lowest since issue 237.8
Spread 0.08
Spread %0.03%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus